AUXL Financial Facts
Net revenues: 109.62MWeighted average common shares outstanding: 50.4M
See Full Income Statement
Total current assets: 262.03M
Short-term investments: 3.84M
See Full Balance Sheet
Auxilium Pharmaceuticals Inc. (AUXL) Earnings
|
Expand Research on AUXL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -11.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/14  |
Q314 | $0.27 | $0.10 | +$0.17 | $109.6M | $101.02M | = |  | | Details | |
| 8/7/14 |
 |
Q214 | -$0.44 | -$0.21 | -$0.23 | $83M | $88.52M | = | | | Details |
| 5/5/14 |
|
Q114 | -$0.39 | -$0.17 | -$0.22 | $8.5M | $89.2M | = | | | Details |
| 2/28/14 |
|
Q413 | $0.27 | $0.22 | +$0.05 | $125.9M | $111.83M | = | | | Details |
| 11/6/13 |
|
Q313 | $0.17 | $0.15 | +$0.02 | $108.1M | $103.66M | = | | | Details |
| 8/1/13 |
|
Q213 | $0.02 | -$0.03 | +$0.05 | $100.5M | $91.43M | = | | | Details |
| 4/29/13 | Q113 | -$0.05 | $0.02 | -$0.07 | $66.2M | $81.23M | = | | | Details | |
| 2/26/13 |
|
Q412 | $1.83 | $1.72 | +$0.11 | $172.5M | $171.2M | = | | | Details |
